Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 26, 2026
TickeronGET DAILY SIGNALS
Banco Macro (BMA) Declines -14.5% Over the Past 30 Days Amid Regional Headwinds

Banco Macro (BMA) Declines -14.5% Over the Past 30 Days Amid Regional Headwinds

Key Takeaways

  • Banco Macro shares have declined roughly 14.5% over the past 30 days, falling from about $68.86 to near $58.90, extending a broader multi-month downtrend.
  • The selloff accelerated in late October after an unexpected outcome in Brazil's presidential election triggered a sharp regional risk-off across Argentine ADRs.
  • Second-quarter 2026 results showed improved profitability, but management lowered its 2026 loan-growth guidance, citing subdued credit demand and rising delinquencies.
  • UBS cut its price target on the stock to $90 from $130 in mid-October while maintaining a Buy rating, reflecting reduced near-term confidence.
  • Over the trailing quarter, the shares are down roughly 34%, weighed down by credit normalization, election uncertainty, and weaker operating momentum.
  • For additional detail on the company, explore dedicated pages for Price Targets, Earnings, and Forecast.
  • Investors tracking systematic strategies can also explore Trending AI Robots for curated, algorithm-driven trading ideas.

Banco Macro (BMA) Company Snapshot and Market Position

Banco Macro S.A. operates as a universal Argentine bank and stands out as the private local lender with the largest branch network in the country. Based in Buenos Aires, it focuses on low- and middle-income individuals along with small and mid-sized companies through its extensive national presence. As of the second quarter of 2026, the bank ran 402 branches with roughly 8,180 employees, serving about 6.36 million retail customers across 23 of Argentina's 24 provinces and more than 228,000 corporate clients.

Its foundation comes from a low-cost, transaction-oriented deposit base that made up about 76% of total liabilities, paired with strong balance-sheet metrics. The Tier 1 capital ratio sat near 28%, liquid assets reached roughly 74% of deposits, and the bank held an 8.2% share of the private-sector loan market. I often view BMA as a useful proxy for tracking Argentina's consumer banking recovery and the broader macroeconomic and credit cycle.

Banco Macro (BMA) Stock Price Moves: Last 30 Days Compared to the Quarter

Over the last 30 days, BMA declined approximately 14.5%, shifting from a closing level near $68.86 in late September to about $58.90 in late October. The decline unfolded gradually rather than in one sharp session, though it included steeper single-day drops toward the end of the period. I checked comparable moves using Tickeron’s AI Screener to see how the stock stacked up against peers in the region.

The quarterly view shows even more pressure. About three months earlier the stock traded near $89, so it has given up approximately 34% over that span. This fits into a longer slide that started after the shares peaked around the low $100s in mid-2026. The ongoing downtrend stems from softening credit growth, asset-quality pressures, and rising political and macro uncertainty in Argentina and the wider region.

Factors Behind the 30-Day Decline

The clearest near-term trigger came from outside the company. An unexpected result in Brazil's presidential runoff election in late October sparked a broad selloff in Brazilian assets that quickly spread to Argentine equities. In premarket trading, BMA traded down several percentage points alongside peers such as GGAL and YPF, as investors reassessed regional fiscal and political risk.

Company-specific elements added to the pressure. When Banco Macro reported second-quarter 2026 results in August, net income rose 39% quarter-over-quarter to ARS 206.8 billion, and adjusted return on equity reached 14.3%. At the same time, management reduced its loan-growth guidance for the year because of weaker credit demand and rising delinquencies. The non-performing loan ratio climbed to 6.25% from 5.40% in the prior quarter, with consumer NPLs continuing to rise even though the bank's asset quality stayed better than the system average.

Analyst moves also influenced sentiment. In mid-October, UBS lowered its price target to $90 from $130 while keeping a Buy rating, which pointed to lower near-term conviction. Together with normalizing credit conditions and Argentina's pre-electoral backdrop, these elements sustained selling pressure through the month.

Quarterly Performance Pressures

The quarterly drop reflects a broader change in the investment story around Argentine banks. After strong loan growth and better profitability, the sector moved into a phase of credit normalization. Banco Macro's lending growth slowed noticeably, and management signaled more modest expansion for 2026, indicating that the favorable financing environment of earlier years was easing.

Asset-quality concerns also gained attention. Although the bank's capital and liquidity stayed solid, rising non-performing loans and lower coverage ratios led investors to reprice risk. Regional political uncertainty, including Brazil's election outcome and Argentina's own pre-electoral setting, added volatility. The result was a de-rating that erased much of the stock's earlier gains, even while underlying earnings held up.

What to Watch Next for BMA Stock

Looking ahead, investors will track the path of Argentina's credit cycle and Banco Macro's progress in stabilizing loan growth while handling non-performing loans. Upcoming earnings will draw attention for updated guidance on lending, net interest margin, and asset quality, especially whether consumer delinquency trends start to level off.

Macroeconomic and political developments will stay important. Inflation, interest rates, and peso exchange-rate shifts directly affect the bank's net interest income and funding costs, while Argentina's pre-electoral calendar and regional dynamics, including moves in Brazil, could keep volatility high. Analyst revisions and any shifts in capital-return plans offer additional signals. These remain factors to monitor rather than a basis for any specific investment decision.

Using Tickeron AI Tools for Deeper Analysis

In my research process, I frequently turn to Tickeron’s AI tools to cross-check patterns and compare performance across similar names. One platform I find particularly useful helps surface systematic, algorithm-driven ideas that align with different risk tolerances and timeframes, giving a practical way to filter through market noise when evaluating names like BMA.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BMA

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


BMA's Indicator enters downward trend

The Aroon Indicator for BMA entered a downward trend on November 20, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 246 similar instances where the Aroon Indicator formed such a pattern. In 201 of the 246 cases the stock moved lower. This puts the odds of a downward move at 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMA as a result. In 66 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.

The Moving Average Convergence Divergence Histogram (MACD) for BMA turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 31 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 72%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

BMA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 2 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 59, placing this stock better than average.

The Tickeron Valuation Rating of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BMA's P/B Ratio (0.001) is slightly lower than the industry average of (1.265). P/E Ratio (0.001) is within average values for comparable stocks, (13.523). Projected Growth (PEG Ratio) (0.520) is also within normal values, averaging (1.194). Dividend Yield (0.033) settles around the average of (0.036) among similar stocks. BMA's P/S Ratio (1.824) is slightly lower than the industry average of (3.751).

The Tickeron Price Growth Rating for this company is 78 (best 1 - 100 worst), indicating slightly worse than average price growth. BMA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are US Bancorp (NYSE:USB), PNC Financial Services Group (NYSE:PNC), Itau Unibanco Banco Holding SA (NYSE:ITUB), Deutsche Bank Aktiengesellschaft (NYSE:DB), Huntington Bancshares (NASDAQ:HBAN), Banco Bradesco SA (NYSE:BBD), Regions Financial Corp (NYSE:RF), KeyCorp (NYSE:KEY).

Industry description

Regional banks have a smaller reach than major banks, and cater mostly to one region of a country, such as a state or within a group of states. They offer services often similar – albeit with some limitations/smaller scale – compared to major banks. Taking deposits, making loans, mortgages, leases, credit cards , fund management, insurance and investment banking. SunTrust Banks, State Street Corp., M&T Bank Corp. are some examples of U.S. regional banks.

Market Cap

The average market capitalization across the Regional Banks Industry is 6.05B. The market cap for tickers in the group ranges from 147.87 to 173.74B. DBSDF holds the highest valuation in this group at 173.74B. The lowest valued company is VLYPP at 147.87.

High and low price notable news

The average weekly price growth across all stocks in the Regional Banks Industry was -5%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 3%. HDB experienced the highest price growth at 6%, while SUPV experienced the biggest fall at -24%.

Volume

The average weekly volume growth across all stocks in the Regional Banks Industry was 25%. For the same stocks of the Industry, the average monthly volume growth was 20% and the average quarterly volume growth was 62%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 52
Price Growth Rating: 50
SMR Rating: 37
Profit Risk Rating: 58
Seasonality Score: 36 (-100 ... +100)
Real Time Patterns 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information

General Information

a regional bank

Industry RegionalBanks

Industry
Regional Banks
Address
Avenida Eduardo Madero 1172
Phone
+54 1152226730
Employees
8490
Web
https://www.macro.com.ar
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.